Mr. Speaker, what I can tell members is that approximately 1,500 doses of an experimental vaccine, designed by the Public Health Agency of Canada, have been produced under license by a U.S. company to support ongoing research. We have offered 800 to 1,000 doses of this experimental vaccine to the World Health Organization as a response to help fight this outbreak.
The World Health Organization continues to evaluate ethical and logistical concerns about the use of experimental vaccines in outbreak areas, and while the safe transportation of our vaccine is an important consideration, these doses are ready to be transported the moment the World Health Organization requests that they be transferred or deployed.